The financing difficulties currently facing small and start-up biotech companies are hitting Lonza. The company warned it may miss its mid-term earnings target in 2008 and may not be able to offset weaker economic growth in the second half. The company expects the macroeconomic challenges to continue in 2009.
Reuters
Wednesday 29 October 2008
Biotech woes hit Lonza
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment